![Randall Kaye](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 331 200 $ in data 31/05/2026
Randall E.
Kaye is an Independent Non-Executive Director at NervGen Pharma Corp.
since 2020.
Former roles include Vice President-Medical Affairs at Scios, Inc. from 2004 to 2006; Chief Medical Officer & SVP-Medical Affairs at Avanir Pharmaceuticals, Inc. from 2013 to 2014; Vice President-Medical Affairs at InterMune, Inc.; Chief Medical Officer at Axsome Therapeutics, Inc. from 2014 to 2016; Chief Medical Officer at Click Therapeutics, Inc. from 2018 to 2019; Chief Medical Officer & EVP at Longboard Pharmaceuticals, Inc.; Chief Scientific Officer at SSI Strategy LLC from 2014 to 2018; and Chief Medical Officer at Neurana Pharmaceuticals, Inc. Education includes undergraduate, graduate, and doctorate degrees from George Washington University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 04/01/2026 | 160.000 ( 0,2% ) | 331 200 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| NERVGEN PHARMA CORP. | Direttore/Membro del Consiglio | 28/10/2020 |
| Società | Posizione | Fine |
|---|---|---|
Click Therapeutics, Inc.
 Click Therapeutics, Inc. Packaged SoftwareTechnology Services Develops and commercializes software as prescription medical treatments for people with unmet medical needs | Direttore Tecnico/Scientifico/R&S | 01/09/2019 |
SSI Strategy LLC
 SSI Strategy LLC Miscellaneous Commercial ServicesCommercial Services Provides bio-tech sciences consulting services | Corporate Officer/Principal | 01/09/2018 |
| AXSOME THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/09/2016 |
| AVANIR PHARMACEUTICALS INC | Direttore Tecnico/Scientifico/R&S | 01/09/2014 |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures & commercializes pharmaceuticals | Direttore Tecnico/Scientifico/R&S | 01/01/2006 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 10 |
|---|---|
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures & commercializes pharmaceuticals | Health Technology |
Avanir Pharmaceuticals, Inc.
 Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products for the treatment of nervous system disorder | Health Technology |
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases | Health Technology |
Axsome Therapeutics, Inc.
 Axsome Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures novel therapies for the management of central nervous system | Health Technology |
Click Therapeutics, Inc.
Click Therapeutics, Inc. Packaged SoftwareTechnology Services Develops and commercializes software as prescription medical treatments for people with unmet medical needs | Technology Services |
George Washington University
 George Washington University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SSI Strategy LLC
SSI Strategy LLC Miscellaneous Commercial ServicesCommercial Services Provides bio-tech sciences consulting services | Commercial Services |
Neurana Pharmaceuticals, Inc.
 Neurana Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for muscle spasms | Health Technology |
NervGen Pharma Corp.
 NervGen Pharma Corp. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops neuroreparative therapeutics and pharmaceutical products for neurological disorders | Health Technology |
Longboard Pharmaceuticals, Inc.
 Longboard Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for neurological diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
